Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamsulosin as Adjuvant Treatment Prior to Endoscopic Ureterolithotomy
NCT03614052Phase 4Terminated
- Sponsor
- Pontificia Universidad Católica de Chile
- Start
- Jun 2018
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in ureterolithiasis comparing Tamsulosin with Placebo (2 arms). Primary endpoint: Stone free rate at 30 days. Started Jun 2018; status: terminated.
02
Drugs
tamsulosin
03
Conditions
ureterolithiasis
Beyond the preview
Go deeper on NCT03614052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03614052.